References for Episode 3: Thalidomide and the profession and the industry
This is a list of material used for episode 3, Thalidomide and the profession and the industry. A transcript of the episode can be found here.
Unfortunately I do no have the information to list my newspaper sources and cannot get it until the British Library opens up again.
Burley, D., ‘Is Thalidomide to Blame?’, The British Medical Journal, 1961, Vol. 1, No. 5219, p. 130.
Bradshaw, S., and Hamilton, R., ‘Industry and Profession’, The Lancet, 1961, Vol. 278, No. 7203, pp. 658-660.
Brynner, R., and Stephens, T., Dark Remedy: The Impact of Thalidomide and its Revival as a Vital Medicine, (New York: 2001).
Duckworth, A., Binns, T., Gorringe, J., et al., ‘Industry and Profession’, The Lancet, 1961, Vol. 278, No., 7201, pp. 554-556.
Dunlop, D., ‘Legislation On Medicines’, The British Medical Journal, 1970, Vol. 3, No. 5725, pp. 760-762.
Florence, L., ‘Is Thalidomide To Blame?’ The British Medical Journal, 1960, Vol. 2, No. 5217, p. 1954.
‘Front Matter’, The British Medical Journal, 1960, Vol. 2, No. 5206, pp. 11-72.
‘Front Matter’, The British Medical Journal, 1961, Vol. 1, No. 5224, pp. 11-62.
‘Front Matter’, The British Medical Journal, 1961, Vol. 2, No. 5259, pp. 11-66.
Fullerton, P., and Kremer, M., ‘Neuropathy After Intake Of Thalidomide (Distaval)’, The British Medical Journal, 1961, Vol. 2, No. 5256, pp. 855-858.
Heathfield, K. and Howe, P., ‘Neuropathy After Thalidomide ("Distaval")’, The British Medical Journal, 1961, Vol. 2, No. 5259, p. 1084.
Howard, S., ‘Industry and Profession’, The Lancet, 1961 Vol. 278, No. 7202, p. 599.
‘Industry and Profession’, The Lancet, 1961, Vol. 278, No. 7199, pp. 411-412.
Jewesbury, E., Burley, D., Simpson, J., et al., ‘Neuropathy After Thalidomide (“Distaval”)’, The British Medical Journal, 1961, Vol. 2, No. 5262, pp. 1286-1287.
Kuenssberg, E., Simpson, J., Stanton, J., ‘Is Thalidomide to Blame?’, The British Medical Journal, 1961, Vol. 1, No. 5221, p. 291.
Magazanik, M., Silent Shock, (Melbourne: 2015).
‘The Pharmaceutical Persuaders: The Industry, the Doctor, and the Clinical Trial’, The Lancet, 1961, Vol. 278, No. 7199, pp. 411-412.
Shafar, J., ‘Is Thalidomide to Blame?’, The British Medical Journal, 1961, Vol. 1, No. 5228, p. 829.
House of Commons Debate
House of Commons Debate, 14 May 1962, vol. 659, col. 902-903.